Kelarmycin dry suspensoid and its preparing process

A technology of clarithromycin and dry suspension is applied in the field of clarithromycin dry suspension and preparation thereof, and can solve the problems of inconvenience in taking, cannot better ensure that patients take medicine according to doctor's orders, and inconvenient for patients to take medicine, Achieve fast onset, good tolerability characteristics, good taste effect
CN1593448AInactive Publication Date: 2005-03-16雅柏药业(中国)有限公司
0 Cites 7 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
雅柏药业(中国)有限公司
Publication Date
2005-03-16
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

The invention discloses a Kelarmycin dry suspensoid and its preparing process consisting of, subjecting the Kelarmycin to twice granulation, i.e. mixing with a quantitative of binding agent, granulation and drying, coating a film dressing layer to the obtained particles with macromolecular dressing material, mixing auxiliary materials including suspension aid, bulking agent, flavoring agent, acid and alkali conditioning agent, forming pellets, and mixing with dressing particles.
Need to check novelty before this filing date? Find Prior Art

Description

【Technical field】

[0001] The invention relates to an antibiotic drug, in particular to a clarithromycin dry suspension and a preparation method thereof. 【Background technique】

[0002] Clarithromycin is a macrolide antibiotic. It is an erythromycin derivative synthesized by structural modification of erythromycin. A common drug for this infection. It is mainly used for the treatment of pharyngitis and tonsillitis caused by Streptococcus pyogenes, acute otitis media, sinusitis, acute bronchitis, acute exacerbation of chronic bronchitis and pneumonia caused by sensitive bacteria; skin and soft tissue infection; or caused by Mycoplasma pneumoniae pneumonia and Chlamydia trachomatis Urethra and cervicitis, etc., can also be used for Legionella infection, or combined with other drugs for the treatment of Mycobacterium avium infection and Helicobacter pylori infection. Clinical application shows that it has the characteristics of high-efficiency bactericidal effect and less toxi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More